Matchbio Limited - Accounts

Matchbio Limited
Statement of Financial Position
As at 31 May 2026

	Notes	2026 £	2025 £ (as restated)
Fixed assets
Tangible fixed assets	3	24,607	60,141
		24,607	60,141
Current assets
Debtors	4	497,434	260,498
Cash at bank and in hand		509,248	2,298,015
		1,006,682	2,558,513
Creditors: amount falling due within one year	5	(279,866)	(168,512)
Net current assets		726,816	2,390,001

Total assets less current liabilities		751,423	2,450,142
Net assets		751,423	2,450,142

Capital and reserves
Called up share capital		4,500,330	4,500,330
Profit and loss account		(3,748,907)	(2,050,188)
Shareholders' funds		751,423	2,450,142

For the year ended 31 May 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of accounts.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime. In accordance with Section 444 of the Companies Act 2006, the income statement has not been delivered to the Registrar of Companies.

The financial statements were approved by the board of directors on 01 September 2026 and were signed on its behalf by:

-------------------------------
Justian Craig Fox
Director

Matchbio Limited
Notes to the Financial Statements
For the year ended 31 May 2026

General Information

Matchbio Limited is a private company, limited by shares, registered in England and Wales, registration number 14876132, registration address C/O Mishcon De Reya, Africa House, 70 Kingsway, London, WC2B 6AH.

The presentation currency is £ sterling.

Accounting policies

Significant accounting policies

Statement of compliance

The financial statements have been prepared in accordance with the Companies Act 2006 and FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

Basis of preparation

The financial statements have been prepared under the historical cost convention.

The financial statements are prepared in sterling which is the functional currency of the company.

Going concern basis

Whilst the Company has not yet generated revenue it has several solid client leads for potential revenue within the next 12 months, including Multinational Pharmaceutical Companies. In addition, much of the ongoing cost of running the business is linked to R&D spend, staff costs and premises costs. All of these are under active management and control and will be adjusted in short order to adopt the going concern basis of accounting in preparing the financial statements.

Foreign currencies

Transactions in foreign currencies are initially recognised at the rate of exchange ruling at the date of the transaction. At the end of each reporting period foreign currency monetary items are translated at the closing rate of exchange. Non-monetary items that are measured at historical cost are translated at the rate ruling at the date of the transaction. All differences are charged to profit or loss.

Taxation

Taxation represents the sum of tax currently payable and deferred tax. Tax is recognised in the statement of income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves.
The company’s liability for current tax is calculated using the tax rates and laws that have been enacted or substantively enacted at the reporting date.
Current and deferred tax assets and liabilities are not discounted

Tangible fixed assets

All fixed assets are initially recorded at cost. Property. plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

2.	Average number of employees Average number of employees during the year was 4 (2025 : 4).

Tangible fixed assets

Cost or valuation	Plant and Machinery	Computer Equipment	Total
	£	£	£
At 01 June 2025	126,545	11,692	138,237
Additions	-	-	-
Disposals	-	-	-
At 31 May 2026	126,545	11,692	138,237
Depreciation
At 01 June 2025	73,854	4,243	78,097
Charge for year	31,636	3,897	35,533
On disposals	-	-	-
At 31 May 2026	105,490	8,140	113,630
Net book values
Closing balance as at 31 May 2026	21,055	3,552	24,607
Opening balance as at 01 June 2025	52,692	7,449	60,141

Debtors: amounts falling due within one year

	2026 £	2025 £
Prepayments & Accrued Income	22,249	22,249
Corporation Tax	429,655	216,989
VAT	45,530	21,260
	497,434	260,498

Creditors: amount falling due within one year

	2026 £	2025 £
Trade Creditors	68,011	59,374
Bank Loans & Overdrafts (Secured)	4,078	7,058
PAYE & Social Security	18,145	45,810
Accrued Expenses	17,917	18,667
Other Creditors	171,715	37,603
	279,866	168,512

6.	Restatement The prior year comparative figures for 31 May 2025 have been restated. The restatement has been made inorder to comply with the Research and Development Expenditure Credit claim made for 31 May 2025.